The evolution of therapeutic modalities drives the adoption of single-use technologies.
Subhasis Banerjee
Advertisement
Subhasis Banerjee, PhD, is a manager of process applications at Millipore India Pvt. Ltd.
Articles by Subhasis Banerjee
This study on a recombinant human follicle stimulating hormone demonstrates the use of virus filters to reduce the risk of contamination.
Membrane-based TFF technology can ease scale-up and provide a higher recovery percentage compared to conventional purification methods.
Advertisement
Latest Updated Articles
Review of SUT Adoption in Biopharma ManufacturingPublished: March 15th 2024 | Updated:
Process Development and Spiking Studies for Virus Filtration of r-hFSHPublished: May 1st 2013 | Updated:
Tangential Flow Filtration for the Recovery of Acellular Pertussis Vaccine ComponentsPublished: October 1st 2009 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
